Clinical Trials · NCT06659744
Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 158,310
- Start date
- Oct 2024
- Locations
- 1 site, United States
- Primary endpoint
- Major adverse cardiac event (MACE), including myocardial infarction, stroke, and all cause death